Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma. - Wikidata - wikimedia - TriplyDB

Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma.

Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma.

http://www.wikidata.org/entity/Q47445963

about

Hypomethylation and aberrant expression of the glioma pathogenesis-related 1 gene in Wilms tumors Frequent long-range epigenetic silencing of protocadherin gene clusters on chromosome 5q31 in Wilms' tumor.The Ras-association domain family (RASSF) members and their role in human tumourigenesis.Tumor suppressor ras association domain family 5 (RASSF5/NORE1) mediates death receptor ligand-induced apoptosis.Promoter hypermethylation-mediated inactivation of multiple Slit-Robo pathway genes in cervical cancer progression DNA methylation biomarkers predict progression-free and overall survival of metastatic renal cell cancer (mRCC) treated with antiangiogenic therapies.Frequent promoter hypermethylation of RASSF1A and CASP8 in neuroblastoma Comparative methylome analysis identifies new tumour subtypes and biomarkers for transformation of nephrogenic rests into Wilms tumour The yin and yang of kidney development and Wilms' tumors DNA Methylation and Flavonoids in Genitourinary Cancers.Expression and roles of Slit/Robo in human ovarian cancer.Epigenetics of kidney cancer and bladder cancer.Genome-wide CpG island methylation analysis implicates novel genes in the pathogenesis of renal cell carcinoma.Decitabine induces G2/M cell cycle arrest by suppressing p38/NF-κB signaling in human renal clear cell carcinoma.The RASSF gene family members RASSF5, RASSF6 and RASSF7 show frequent DNA methylation in neuroblastoma.SLIT2 promoter methylation analysis in neuroblastoma, Wilms' tumour and renal cell carcinoma Therapeutic targets in the ARF tumor suppressor pathway.Aberrant promoter hypermethylation of PBRM1, BAP1, SETD2, KDM6A and other chromatin-modifying genes is absent or rare in clear cell RCC CpG methylation profiling in VHL related and VHL unrelated renal cell carcinoma.Genome-wide screen of promoter methylation identifies novel markers in melanoma.An association between overexpression of DNA methyltransferase 3B4 and clear cell renal cell carcinoma.Epigenetics of renal cell carcinoma: the path towards new diagnostics and therapeutics Hypomethylating agents for urologic cancers.The epigenetics of renal cell tumors: from biology to biomarkers.Evaluating DAPK as a therapeutic target.The genetic factors contributing to the development of Wilm's tumor and their clinical utility in its diagnosis and prognosis.Impact of O6-methylguanine-DNA methyltransferase expression on the drug resistance of clear cell renal cell carcinoma.Ras signaling through RASSF proteins.The epigenetic landscape of renal cancer.Identification of candidate tumour suppressor genes frequently methylated in renal cell carcinoma.Functional epigenomics approach to identify methylated candidate tumour suppressor genes in renal cell carcinoma Characterization of a 3;6 translocation associated with renal cell carcinoma.Quantitative methylation profiling of renal tumors and the discovery of a new generation of molecular markers.Clinical significance of p16INK4A and p14ARF promoter methylation in renal cell carcinoma: a meta-analysis SFRP1 CpG island methylation locus is associated with renal cell cancer susceptibility and disease recurrence.Frequent SLIT2 promoter methylation in the serum of patients with ovarian cancer.Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma Genetic and epigenetic analyses guided by high resolution whole-genome SNP array reveals a possible role of in Wilms tumour susceptibility

P2860

Q24678285-83EDF0C9-B0A6-45C6-8874-942A1BD2A529 Q30945124-1D8A3B01-EE1D-4092-B85D-228B2FB20CA4 Q31121564-26D0CE37-0CDD-40FA-86FF-13BA2F0C9189 Q34251431-E361D2FB-CF61-49CD-A277-35B51F217063 Q34695790-F38A759D-608F-43D4-B7B0-FDED8056253A Q35122019-DD73204B-5930-4A5C-B7CE-379B86C82447 Q35126668-73A681FB-DD11-430B-A569-F4B8782A3990 Q35163343-C57904DF-6595-4DFC-BBB4-B41A6FA5F298 Q35173260-B74BEF84-75D7-4841-B23C-D0AEAB76000F Q35623184-EFD1F369-8FF6-4D6D-A0BB-EDAF980FFF3E Q35759877-5FB71BF0-34C4-45DE-B1FC-57EB7049D912 Q35857807-C2FB05BB-711B-4228-A6EA-F76FE13FC023 Q35911266-4CD33B00-49C4-4A2B-94E7-76B04AB15959 Q36261661-E3C88389-CDC0-4692-B487-8C9A7D124068 Q36383883-8B37C02F-B2DE-46CF-8BB9-02FBB23D317F Q36694377-F2EF0D60-5CB5-4962-B706-3253A2544FB6 Q36879301-C2DD447A-4F01-4638-8D1F-0557C6971F7D Q37089505-49CDE907-0EF9-498B-8C9E-A1DD2B4ED903 Q37233603-B2386351-3EB6-41E9-9FDF-A7DB82604F87 Q37287368-BC223B2D-EB94-48F8-9B6D-325C84678AF5 Q37746112-FDE94AD0-D51F-484D-A157-5425FFA008EC Q37785109-931E51C8-6C23-48F4-9BE8-53C59E64D67E Q37854737-29F1B8DD-B158-4114-9AC5-C4AD21742CDE Q38016153-ACA385A2-3300-4782-9889-95C47753FB18 Q38168688-147C0672-C5E6-495C-B02D-4DEC7F765706 Q38764772-DA9D24C3-E30A-4F08-9871-29BC16BA1C99 Q38851881-266DCEB9-6EFD-4AA3-833F-8F00F67BF671 Q38862017-9E5237D3-2BE0-4216-8F1C-365C06CF7357 Q39021700-12000222-8879-43F6-9B0E-9271BABC0C3A Q39739609-571303CB-4BCB-4436-8A20-F0D9911536CA Q40025069-99558D47-A05C-48EE-A176-53D02A30C25D Q40186267-C1002D0A-D2CB-4BAE-BA7C-7DCD383EFDBD Q40340402-43CA1A3C-4DAB-4E1C-AB43-5F8C9DEAB543 Q42362790-4F293CCA-87F1-40D8-8E02-5F78AEF49167 Q48019854-6220D6CD-DDF2-46A5-BF94-E89FCA850854 Q54309038-970A6FAE-E38B-40A0-BF28-7E4EA3F1B3A1 Q56444295-C8A770F3-AD1D-429F-BC13-49FB248FEE0E Q57821557-857AC26D-B566-440C-AD37-78F2A7D5CA41

P2860

Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma.

http://www.wikidata.org/entity/Q47445963

description

2003 nî lūn-bûn

@nan

2003年の論文

@ja

2003年学术文章

@wuu

2003年学术文章

@zh-cn

2003年学术文章

@zh-hans

2003年学术文章

@zh-my

2003年学术文章

@zh-sg

2003年學術文章

@yue

2003年學術文章

@zh

2003年學術文章

@zh-hant

name

Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma.

@en

Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma.

@nl

type

label

Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma.

@en

Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma.

@nl

prefLabel

Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma.

@en

Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma.

@nl

P1433

Q47445963-847B5AEF-7FBE-4EA9-A4E4-3F79B5A7DC16

P1476

Q47445963-CC0CAF4D-1236-4B58-8CFC-544E7EE5B344

P2093

Q47445963-140FF784-8C83-4F5E-82AC-2D362BAA2266

Q47445963-4C572847-864D-49BE-961D-CF2245F95BB3

Q47445963-57E2742B-8B8E-4AF3-8EDA-BA5AD8EA19E4

Q47445963-57F1C912-679A-4FA1-887C-FCA24C8AD4E1

Q47445963-5D454A23-2F7A-4BEB-B8D0-5B3FD0DB029D

Q47445963-5ED66DDC-F108-482B-A412-BCF29B97E289

Q47445963-63CC7F70-B756-48FC-80A8-FEE9C6C57720

Q47445963-77000010-F8E1-430A-9BFA-5127213D89CF

Q47445963-7CFE5B02-7AC7-458E-A70C-9455A4DF119E

Q47445963-A408E31C-8459-4AF5-A85E-311EEB65ACF1

P2860

Q47445963-052F1416-03A9-47C9-A8B4-E01BAC14FA29

Q47445963-0D032B53-7696-4068-BE3A-C252C61FE44B

Q47445963-11E1CAB0-C809-45D8-8E9A-99151F79C5A0

Q47445963-14BBAFF9-D45E-4671-BD20-C9C6AA29212E

Q47445963-18EA7AFF-7344-43AA-B428-6C8378979625

Q47445963-1AEE2375-E37C-4C3B-BA7D-302CEF64FC53

Q47445963-25F0A7CC-FF74-41C4-86FA-79B627DD3893

Q47445963-2D26EE85-6516-4CAB-9892-FA15CAF0C00F

Q47445963-2E5B3C30-4E18-41B7-A359-4351AD6561BE

Q47445963-2E6B1A64-21F0-46A2-A1D6-63020A86DD65

P2888

Q47445963-A2E08EAD-A5FA-4EAD-8253-8ADDF56EF5B0

P304

Q47445963-ECB7559F-C817-4768-BF9E-DAC6F5E425C4

P31

Q47445963-1168B444-4A9E-429E-B17D-AFED04090203

P356

Q47445963-AFD7089F-FABA-4CBC-A9C4-0309FC72EC5A

P407

Q47445963-AA1C96DB-A228-43DE-BC15-54D34FD0B3CF

P433

Q47445963-E61B8B24-149C-414D-9500-A499BD1EDC80

P478

Q47445963-FC5FFA3A-516F-49FD-A8B0-FE231ACE7FC7

P50

Q47445963-52571F81-5402-42B8-A1EE-D7F48211A652

P577

Q47445963-C41F6B88-31A6-468F-BFD2-97F51AC229E7

P5875

Q47445963-FC7B7873-AD6D-4FAC-976D-35A9880D893F

P698

Q47445963-2D5FC42A-3ADC-44FA-B8FB-86C82EFCCF70

P356

P1433

P1476

Multigene methylation analysis of Wilms' tumour and adult renal cell carcinoma.

@en

P2093

Dean Gentle

http://www.w3.org/2001/XMLSchema#string

Dewi Astuti

http://www.w3.org/2001/XMLSchema#string

Eamonn R Maher

http://www.w3.org/2001/XMLSchema#string

Farida Latif

http://www.w3.org/2001/XMLSchema#string

Fiona Macdonald

http://www.w3.org/2001/XMLSchema#string

JouAnn Lee

http://www.w3.org/2001/XMLSchema#string

Kate J Wagner

http://www.w3.org/2001/XMLSchema#string

Luke B Hesson

http://www.w3.org/2001/XMLSchema#string

Mark R Morris

http://www.w3.org/2001/XMLSchema#string

Masahiro Yao

http://www.w3.org/2001/XMLSchema#string

P2860

The tumour suppressor protein VHL targets hypoxia-inducible factors for oxygen-dependent proteolysis

Epigenetic inactivation of RASSF1A in lung and breast cancers and malignant phenotype suppression

Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands

CpG island methylator phenotype in colorectal cancer

In vivo gene expression profile analysis of metallothionein in renal cell carcinoma

Wilms tumor and the WT1 gene

Aberrant promoter methylation and silencing of the RASSF1A gene in pediatric tumors and cell lines

The H-cadherin (CDH13) gene is inactivated in human lung cancer

H-cadherin, a novel cadherin with growth inhibitory functions and diminished expression in human breast cancer

Methylation matters

P2888

P304

6794-6801

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.ONC.1206914

http://www.w3.org/2001/XMLSchema#string

P407

P433

43

http://www.w3.org/2001/XMLSchema#string

P478

22

http://www.w3.org/2001/XMLSchema#string

P50

P577

2003-10-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

5466954

http://www.w3.org/2001/XMLSchema#string

P698

14555992

http://www.w3.org/2001/XMLSchema#string